The Huddle | November 23, 2022
The UW Medicine Garvey Institute for Brain Health Solutions is awarding over $1 million to develop and test innovative approaches to caring for adolescents and young adults with mental health and addiction problems. The focus on adolescent and young adult mental health was driven by the steadily increasing rates of depression, anxiety and suicidal thoughts in adolescents and young adults over the past decade.
Psychology Today | October 20, 2022
A new study published in Psychiatric Services by members of the BRiTE Center shows how AI natural language processing can detect cognitive disorders in texts as effectively as human clinicians. Authors include Justin Tauscher, PhD, MS, Ayesha Chander, MRes, Trevor Cohen, MBChB, PhD, FACMI, and Dror Ben-Zeev, PhD. The work was supported by an innovation grant from the Garvey Institute for Brain Health Solutions.
UW Medicine newsroom | October 11, 2022
Members of the BRiTE Center including Justin Tauscher, PhD, MS, Ayesha Chander, MRes, Trevor Cohen, MBChB, PhD, FACMI, and Dror Ben-Zeev, PhD, published findings in Psychiatric Services showing that algorithms are as good as trained human evaluators at identifying red-flag language in text messages from people with serious mental illness. The work was supported by an innovation grant from the Garvey Institute for Brain Health Solutions.
Department news | September 29, 2022
Two recent grants to give a bit of a glimpse of the wide range of exciting work going on in the department’s research labs.
UW Tacoma News | August 4, 2022
UW Tacoma Assistant Professor Sunny Cheng's research focuses on mental health, particularly the impact of early intervention and screening. Dr. Cheng's research is funded in part by the Garvey Institute for Brain Health Solutions.
Department News | June 28, 2022
Through our Small Grants Program launched in 2020, and with support from the Garvey Institute for Brain Health Solutions, we allocated nearly $100,000 to a terrific set of diverse proposals from faculty, staff and trainees on a wide range of topics. Kathleen Pagulayan, PhD, Abigail Schindler, PhD, Rebecca Hendrickson, PhD, and Sean Gibbons, PhD, completed […]
The Scientist | June 13, 2022
Researchers are turning to the immune system for help in treating addiction and preventing overdose including Marco Pravetoni, PhD, who is developing monoclonal antibodies against fentanyl and fentanyl analogs. Note: you need to register (for free) in order to view this article
Pharmaceutical Technology | May 30, 2022
Even with academic collaborations, private players are lagging behind public institutions in finding new treatments for opioid addiction. Marco Pravetoni, PhD, is currently working on developing a potential vaccine aimed at oxycodone, which is in Phase I trials, and aims to get vaccines targeting other drugs like fentanyl or heroin into the clinic in the coming years.
Right as Rain | May 25, 2022
Mollie Forrester, MSW, LICSW, explains how to break up with a therapist if treatment goals are not being met. Written by Lori Mae Yvette Calibuso Acob, Brain Health Science Writing intern at the Garvey Institute for Brain Health Solutions.
Garvey Institute news | April 30, 2022
Our Innovation Grants Program launched in 2020 funded a project led by Kristen Lindgren, PhD, ABPP and Michele Bedard-Gilligan, PhD, called “Improving Washingtonians’ resilience and recovery from traumatic events with a Trauma-Informed Care ECHO Clinic”.